Israeli Startup QuantHealth Raises $45 Million to Revolutionize Drug Development with AI
How 2 Israeli newsrooms covered this story — translated into English and compared side by side.
By יעל אנקר
First reported by Calcalist · Aug 4, 2026
What happened
Israeli startup QuantHealth raised $45 million to expand its AI platform that simulates clinical trials before they start, aiming to reduce drug development failures and speed up research. The technology helps optimize trial design but does not replace human trials. The funds will enhance AI models and expand disease coverage, potentially accelerating new treatments to patients.
- 01QuantHealth raised $45 million to expand its AI clinical trial simulation platform.
- 02The AI predicts patient responses and improves trial design before human testing.
- 03The platform has simulated over 600 trials across 30+ medical conditions.
- 04Funds will enhance AI models and broaden disease coverage to 40+ illnesses.
- 05Technology aids trial planning but does not replace essential human clinical trials.
- 06AI could become a key tool to speed up drug development and delivery to patients.
Summary translated & synthesized from the sources below by baba. Read each original for the full report.
Full coverage · 2 outlets
The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.
